Abstractα-Glucosidase inhibitors are described as the most effective in reducing post-prandial hyperglycaemia (PPHG) from all available anti-diabetic drugs used in the management of type 2 diabetes mellitus. As flavonoids are promising modulators of this enzyme’s activity, a panel of 44 flavonoids, organised in five groups, was screened for their inhibitory activity of α-glucosidase, based on in vitro structure–activity relationship studies. Inhibitory kinetic analysis and molecular docking calculations were also applied for selected compounds. A flavonoid with two catechol groups in A- and B-rings, together with a 3-OH group at C-ring, was the most active, presenting an IC50 much lower than the one found for the most widely prescribed α-glucosidase inhibitor, acarbose. The present work suggests that several of the studied flavonoids have the potential to be used as alternatives for the regulation of PPHG.
Betulinic acid (BA) and its natural analogues betulin (BN), betulonic (BoA), and 23-hydroxybetulinic (HBA) acids are lupane-type pentacyclic triterpenoids. They are present in many plants and display important biological activities. This review focuses on the chemical transformations used to functionalize BA/BN/BoA/HBA in order to obtain new derivatives with improved biological activity, covering the period since 2013 to 2018. It is divided by the main chemical transformations reported in the literature, including amination, esterification, alkylation, sulfonation, copper(I)-catalyzed alkyne-azide cycloaddition, palladium-catalyzed cross-coupling, hydroxylation, and aldol condensation reactions. In addition, the synthesis of heterocycle-fused BA/HBA derivatives and polymer‒BA conjugates are also addressed. The new derivatives are mainly used as antitumor agents, but there are other biological applications such as antimalarial activity, drug delivery, bioimaging, among others.
Liver fructose 1,6-bisphosphatase
(FBPase) is a recognized regulatory
enzyme of the gluconeogenesis pathway, which has emerged as a valid
target to control gluconeogenesis-mediated overproduction of glucose.
As such, the management of diabetes with FBPase inhibitors represents
a potential alternative for the currently used antidiabetic agents.
In this study, the FBPase inhibition of a panel of 55 structurally
related flavonoids was tested, through a microanalysis screening system.
Then, a subset of seven active inhibitors and their close chemical
relatives were further evaluated by molecular dynamics (MD) simulations
using a linear interaction energy (LIE) approach. The results obtained
showed that D14 (herbacetin) was the most potent inhibitor,
suggesting that the presence of −OH groups at the C-3, C-4′,
C-5, C-7, and C-8 positions, as well as the double bond between C-2
and C-3 and the 4-oxo function at the pyrone ring, are favorable for
the intended effect. Furthermore, D14 (herbacetin) is
stabilized by a strong interaction with the Glu30 side chain and the
Thr24 backbone of FBPase. This is the first investigation studying
the in vitro inhibitory effect of a panel of flavonoids against human
liver FBPase, thus representing a potentially important step for the
search and design of novel inhibitors of this enzyme.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.